From Wikipedia, the free encyclopedia
Pharmaceutical drug classification
ATC code R03 Drugs for obstructive airway diseases is a therapeutic subgroup of the
Anatomical Therapeutic Chemical Classification System , a system of alphanumeric codes developed by the
World Health Organization (WHO) for the classification of
drugs and other medical products.
[1]
[2]
[3] Subgroup R03 is part of the anatomical group
R Respiratory system .
[4]
Codes for
veterinary use (
ATCvet codes ) can be created by placing the letter Q in front of the human ATC code: for example, QR03 .
[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list. National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
R03A Adrenergics, inhalants
R03AA Alpha- and beta-adrenoreceptor agonists
R03AA01
Epinephrine
R03AB Non-selective beta-adrenoreceptor agonists
R03AB02
Isoprenaline
R03AB03
Orciprenaline
R03AC Selective beta-2-adrenoreceptor agonists
R03AC02
Salbutamol
R03AC03
Terbutaline
R03AC04
Fenoterol
R03AC05
Rimiterol
R03AC06
Hexoprenaline
R03AC07
Isoetarine
R03AC08
Pirbuterol
R03AC09
Tretoquinol
R03AC10
Carbuterol
R03AC11
Tulobuterol
R03AC12
Salmeterol
R03AC13
Formoterol
R03AC14
Clenbuterol
R03AC15
Reproterol
R03AC16
Procaterol
R03AC17
Bitolterol
R03AC18
Indacaterol
R03AC19
Olodaterol
R03AH Combinations of adrenergics
R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
R03AK01 Epinephrine and other drugs for obstructive airway diseases
R03AK02 Isoprenaline and other drugs for obstructive airway diseases
R03AK04 Salbutamol and
sodium cromoglicate
R03AK05 Reproterol and sodium cromoglicate
R03AK06 Salmeterol and
fluticasone
R03AK07 Formoterol and
budesonide
R03AK08 Formoterol and
beclometasone
R03AK09 Formoterol and
mometasone
R03AK10
Vilanterol and fluticasone furoate
R03AK11 Formoterol and fluticasone
R03AK12 Salmeterol and budesonide
R03AK13 Salbutamol and beclometasone
R03AK14
Indacaterol and mometasone
R03AK15
Salbutamol and
budesonide
R03AL Adrenergics in combinations with anticholinergics incl. triple combinations with corticosteroids
R03AL01 Fenoterol and
ipratropium bromide
R03AL02
Salbutamol and ipratropium bromide
R03AL03
Vilanterol and umeclidinium bromide
R03AL04
Indacaterol and glycopyrronium bromide
R03AL05
Formoterol and aclidinium bromide
R03AL06 Olodaterol and
tiotropium bromide
R03AL07
Formoterol and glycopyrronium bromide
R03AL08
Vilanterol, umeclidinium bromide, and fluticasone furoate
R03AL09
Formoterol, glycopyrronium bromide and beclometasone
R03AL10
Formoterol and
tiotropium bromide
R03AL11
Formoterol, glycopyrronium bromide, and budesonide
R03AL12
Indacaterol, glycopyrronium bromide and mometasone
R03B Other drugs for obstructive airway diseases, inhalants
R03BA Glucocorticoids
R03BA01
Beclometasone
R03BA02
Budesonide
R03BA03
Flunisolide
R03BA04
Betamethasone
R03BA05 Fluticasone
R03BA06
Triamcinolone
R03BA07
Mometasone
R03BA08
Ciclesonide
R03BA09
Fluticasone furoate
R03BB Anticholinergics
R03BB01
Ipratropium bromide
R03BB02
Oxitropium bromide
R03BB03
Stramoni preparations
R03BB04
Tiotropium bromide
R03BB05
Aclidinium bromide
R03BB06
Glycopyrronium bromide
R03BB07
Umeclidinium bromide
R03BB08
Revefenacin
R03BB54 Tiotropium bromide, combinations
R03BC Antiallergic agents, excluding corticosteroids
R03BC01
Cromoglicic acid
R03BC03
Nedocromil
R03BX Other drugs for obstructive airway diseases, inhalants
R03BX01
Fenspiride
R03C Adrenergics for systemic use
R03CA Alpha- and beta-adrenoreceptor agonists
R03CA02
Ephedrine
R03CB Non-selective beta-adrenoreceptor agonists
R03CB01
Isoprenaline
R03CB02
Methoxyphenamine
R03CB03
Orciprenaline
R03CB51 Isoprenaline, combinations
R03CB53 Orciprenaline, combinations
R03CC Selective beta-2-adrenoreceptor agonists
R03CC02
Salbutamol
R03CC03
Terbutaline
R03CC04
Fenoterol
R03CC05
Hexoprenaline
R03CC06
Isoetarine
R03CC07
Pirbuterol
R03CC08
Procaterol
R03CC09
Tretoquinol
R03CC10
Carbuterol
R03CC11
Tulobuterol
R03CC12
Bambuterol
R03CC13
Clenbuterol
R03CC14
Reproterol
R03CC15
Formoterol
R03CC53 Terbutaline, combinations
R03CC63 Clenbuterol and
ambroxol
QR03CC90 Clenbuterol, combinations
R03CK Adrenergics and other drugs for obstructive airway diseases
R03D Other systemic drugs for obstructive airway diseases
R03DA Xanthines
R03DA01
Diprophylline
R03DA02
Choline theophyllinate
R03DA03
Proxyphylline
R03DA04
Theophylline
R03DA05
Aminophylline
R03DA06
Etamiphylline
R03DA07
Theobromine
R03DA08
Bamifylline
R03DA09
Acefylline piperazine
R03DA10
Bufylline
R03DA11
Doxofylline
R03DA12
Mepyramine theophyllinacetate
R03DA20 Combinations of xanthines
R03DA51 Diprophylline, combinations
R03DA54 Theophylline, combinations excluding psycholeptics
R03DA55 Aminophylline, combinations
R03DA57 Theobromine, combinations
R03DA74 Theophylline, combinations with psycholeptics
R03DB Xanthines and adrenergics
R03DB01 Diprophylline and adrenergics
R03DB02 Choline theophyllinate and adrenergics
R03DB03 Proxyphylline and adrenergics
R03DB04 Theophylline and adrenergics
R03DB05 Aminophylline and adrenergics
R03DB06 Etamiphylline and adrenergics
R03DC Leukotriene receptor antagonists
R03DC01
Zafirlukast
R03DC02
Pranlukast
R03DC03
Montelukast
R03DC04
Ibudilast
R03DC53 Montelukast, combinations
R03DX Other systemic drugs for obstructive airway diseases
R03DX01
Amlexanox
R03DX02
Eprozinol
R03DX03
Fenspiride
R03DX05
Omalizumab
R03DX06
Seratrodast
R03DX07
Roflumilast
R03DX08
Reslizumab
R03DX09
Mepolizumab
R03DX10
Benralizumab
R03DX11
Tezepelumab
References